Avi Ashkenazi, PhD

SchoolUCSF School of Medicine
DepartmentBiochemistry and Biophysics
Address3333 Calif. St,Laurel Heights
San Francisco CA 94118
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Ashkenazi A, Salvesen G. Regulated cell death: signaling and mechanisms. Annu Rev Cell Dev Biol. 2014; 30:337-56. PMID: 25150011.
      View in: PubMed
    2. Sidrauski C, Acosta-Alvear D, Khoutorsky A, Vedantham P, Hearn BR, Li H, Gamache K, Gallagher CM, Ang KK, Wilson C, Okreglak V, Ashkenazi A, Hann B, Nader K, Arkin MR, Renslo AR, Sonenberg N, Walter P. Pharmacological brake-release of mRNA translation enhances cognitive memory. Elife. 2013; 2:e00498. PMID: 23741617; PMCID: PMC3667625.
    3. Ashkenazi A. Directing cancer cells to self-destruct with pro-apoptotic receptor agonists. Nat Rev Drug Discov. 2008 Dec; 7(12):1001-12. PMID: 18989337.
      View in: PubMed
    4. Ashkenazi A, Herbst RS. To kill a tumor cell: the potential of proapoptotic receptor agonists. J Clin Invest. 2008 Jun; 118(6):1979-90. PMID: 18523647; PMCID: PMC2396896.
    5. Ashkenazi A. Targeting the extrinsic apoptosis pathway in cancer. Cytokine Growth Factor Rev. 2008 Jun-Aug; 19(3-4):325-31. PMID: 18495520.
      View in: PubMed
    6. Ashkenazi A. Targeting death and decoy receptors of the tumour-necrosis factor superfamily. Nat Rev Cancer. 2002 Jun; 2(6):420-30. PMID: 12189384.
      View in: PubMed
    7. Ashkenazi A, Dixit VM. Death receptors: signaling and modulation. Science. 1998 Aug 28; 281(5381):1305-8. PMID: 9721089.
      View in: PubMed
    8. Ashkenazi A, Chamow SM. Immunoadhesins as research tools and therapeutic agents. Curr Opin Immunol. 1997 Apr; 9(2):195-200. PMID: 9099788.
      View in: PubMed
    Back to TOP